Ear, nose and throat manifestations in patients with primary antibody deficiencies

Recurrent ear, nose, and throat (ENT) infections are common presenting symptoms in patients with primary antibody deficiencies , but sometimes they remain undiagnosed for many years and are subjected to different antibiotics because of a lack of experience in immunodeficiencies. In order to determin...

Full description

Bibliographic Details
Main Authors: Aghamohammadi A, Jalali F, Farhoudi A, Pourpak Z, Rezaei N, Khazali SH, Hosseini Nik H
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2001-09-01
Series:Acta Medica Iranica
Subjects:
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/2428
id doaj-90ba15733d4c4fd0967d31a2786518ea
record_format Article
spelling doaj-90ba15733d4c4fd0967d31a2786518ea2020-11-25T02:11:20ZengTehran University of Medical SciencesActa Medica Iranica0044-60251735-96942001-09-01393Ear, nose and throat manifestations in patients with primary antibody deficiencies Aghamohammadi A0 Jalali F1 Farhoudi A2 Pourpak Z3 Rezaei N4 Khazali SH5 Hosseini Nik H6 Recurrent ear, nose, and throat (ENT) infections are common presenting symptoms in patients with primary antibody deficiencies , but sometimes they remain undiagnosed for many years and are subjected to different antibiotics because of a lack of experience in immunodeficiencies. In order to determin the frequency of ENT symptoms among the patients with antibody deficiencies, 83 antibody deficient patients were studied from 1980 during a 20-year period, and their ENT symptoms were registered.This historical cohort study comprised of 83 patients including 25 X link agammaglubulinemi, (XLA) 40 common variable immunodeficiency (CVID), 14 IgA deficiency (IgA-D); 50 male, 33 female. The average length of time between onset and diagnosis was 40 months in our patients. Seventy-two of our patients (86.7%), had recurrent ENT symptoms (sinusitis, otitis and/or mastoidits) during the course of their disease. Each XLA patient had experienced 3.6 episodes of otitis per year, but after diagnosis it decreased to 0.7 episode per year. This decrease was about 5.8 folds in CVID (3.8 to 0.65) and 1.4 folds in IgA (2.2 to 1.6) these results show that a significant number of antibody deficient patients can be present with ENT symptoms (48% in this study). Diagnostic dealy was not much different from other reports. Early diagnosisand treatment of immunodeficiencies significantly prevents recurrent infections hence preventing long time complications https://acta.tums.ac.ir/index.php/acta/article/view/2428Primary antibody deficienciesSinusitisOtitis media
collection DOAJ
language English
format Article
sources DOAJ
author Aghamohammadi A
Jalali F
Farhoudi A
Pourpak Z
Rezaei N
Khazali SH
Hosseini Nik H
spellingShingle Aghamohammadi A
Jalali F
Farhoudi A
Pourpak Z
Rezaei N
Khazali SH
Hosseini Nik H
Ear, nose and throat manifestations in patients with primary antibody deficiencies
Acta Medica Iranica
Primary antibody deficiencies
Sinusitis
Otitis media
author_facet Aghamohammadi A
Jalali F
Farhoudi A
Pourpak Z
Rezaei N
Khazali SH
Hosseini Nik H
author_sort Aghamohammadi A
title Ear, nose and throat manifestations in patients with primary antibody deficiencies
title_short Ear, nose and throat manifestations in patients with primary antibody deficiencies
title_full Ear, nose and throat manifestations in patients with primary antibody deficiencies
title_fullStr Ear, nose and throat manifestations in patients with primary antibody deficiencies
title_full_unstemmed Ear, nose and throat manifestations in patients with primary antibody deficiencies
title_sort ear, nose and throat manifestations in patients with primary antibody deficiencies
publisher Tehran University of Medical Sciences
series Acta Medica Iranica
issn 0044-6025
1735-9694
publishDate 2001-09-01
description Recurrent ear, nose, and throat (ENT) infections are common presenting symptoms in patients with primary antibody deficiencies , but sometimes they remain undiagnosed for many years and are subjected to different antibiotics because of a lack of experience in immunodeficiencies. In order to determin the frequency of ENT symptoms among the patients with antibody deficiencies, 83 antibody deficient patients were studied from 1980 during a 20-year period, and their ENT symptoms were registered.This historical cohort study comprised of 83 patients including 25 X link agammaglubulinemi, (XLA) 40 common variable immunodeficiency (CVID), 14 IgA deficiency (IgA-D); 50 male, 33 female. The average length of time between onset and diagnosis was 40 months in our patients. Seventy-two of our patients (86.7%), had recurrent ENT symptoms (sinusitis, otitis and/or mastoidits) during the course of their disease. Each XLA patient had experienced 3.6 episodes of otitis per year, but after diagnosis it decreased to 0.7 episode per year. This decrease was about 5.8 folds in CVID (3.8 to 0.65) and 1.4 folds in IgA (2.2 to 1.6) these results show that a significant number of antibody deficient patients can be present with ENT symptoms (48% in this study). Diagnostic dealy was not much different from other reports. Early diagnosisand treatment of immunodeficiencies significantly prevents recurrent infections hence preventing long time complications
topic Primary antibody deficiencies
Sinusitis
Otitis media
url https://acta.tums.ac.ir/index.php/acta/article/view/2428
work_keys_str_mv AT aghamohammadia earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT jalalif earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT farhoudia earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT pourpakz earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT rezaein earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT khazalish earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT hosseininikh earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
_version_ 1724914907658321920